Results 191 to 200 of about 65,793 (248)
Some of the next articles are maybe not open access.
Thrombosis and Haemostasis, 2005
SummaryCardiovascular diseases are a major cause of mortality in the developed world. Efficacy of thrombolysis plays an important role in the management of acute myocardial infarction and cerebral insult both in the acute event and in the long-term outcome of these patients.
Stefan, Pfaffenberger +6 more
openaire +2 more sources
SummaryCardiovascular diseases are a major cause of mortality in the developed world. Efficacy of thrombolysis plays an important role in the management of acute myocardial infarction and cerebral insult both in the acute event and in the long-term outcome of these patients.
Stefan, Pfaffenberger +6 more
openaire +2 more sources
Current Opinion in Internal Medicine, 2002
The ability to use an effective treatment constitutes a main concern in the management of acute ischemic stroke. Randomized trials have so far failed to demonstrate any beneficial effect of neuroprotective agents on neurologic outcome after an acute stroke. Thrombolytic agents can achieve early recanalization of an occluded intracerebral artery.
Katayoun, Vahedi +1 more
openaire +2 more sources
The ability to use an effective treatment constitutes a main concern in the management of acute ischemic stroke. Randomized trials have so far failed to demonstrate any beneficial effect of neuroprotective agents on neurologic outcome after an acute stroke. Thrombolytic agents can achieve early recanalization of an occluded intracerebral artery.
Katayoun, Vahedi +1 more
openaire +2 more sources
European Journal of Neurology, 2012
Background and purposeHemiplegia at stroke onset may be considered a contraindication for thrombolytic therapy. We describe the outcome of patients with ischaemic stroke presenting with hemiplegia and treated with intravenous alteplase (tPA).MethodsAll patients treated with tPA for acute ischaemic stroke between 1995 and 2010 were prospectively ...
Meretoja A. +11 more
openaire +2 more sources
Background and purposeHemiplegia at stroke onset may be considered a contraindication for thrombolytic therapy. We describe the outcome of patients with ischaemic stroke presenting with hemiplegia and treated with intravenous alteplase (tPA).MethodsAll patients treated with tPA for acute ischaemic stroke between 1995 and 2010 were prospectively ...
Meretoja A. +11 more
openaire +2 more sources
Thrombosis and Haemostasis, 1999
SummaryThe possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ...
openaire +2 more sources
SummaryThe possibility of lysing clots by the direct intravascular application of ultrasound was described first in 1974 in an animal experiment. However research on therapeutic ultrasound for thrombolysis gained momentum in the early 1980s and is now divided into several directions: 1) pharmacological thrombolysis supported by externally applied ...
openaire +2 more sources
British Journal of Haematology, 2009
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +2 more sources
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +2 more sources
Ultrasonics, 2008
Ultrasound energy for thrombolysis dates back to 1976. Trubestein et al. demonstrated first in vitro that a rigid wire delivery low frequency ultrasound energy could disrupt clot. These investigators also showed that this system had potential for peripheral arterial clot dissolution in vivo in animal studies [G. Trubestein, C. Engel, F. Etzel, Clinical
Robert J, Siegel, Huai, Luo
openaire +2 more sources
Ultrasound energy for thrombolysis dates back to 1976. Trubestein et al. demonstrated first in vitro that a rigid wire delivery low frequency ultrasound energy could disrupt clot. These investigators also showed that this system had potential for peripheral arterial clot dissolution in vivo in animal studies [G. Trubestein, C. Engel, F. Etzel, Clinical
Robert J, Siegel, Huai, Luo
openaire +2 more sources
Cardiologia (Rome, Italy), 1995
In this study, we assessed one particular aspect of the arrhythmogenic phenomena that occur during reperfusion secondary to thrombolysis, that is the therein involved metabolic mechanisms. The employed experimental model (isolated Langendorff-perfused rat heart) allowed us to distinguish which factor involved during ischemia, low coronary flow or low ...
B. Caro +3 more
openaire +3 more sources
In this study, we assessed one particular aspect of the arrhythmogenic phenomena that occur during reperfusion secondary to thrombolysis, that is the therein involved metabolic mechanisms. The employed experimental model (isolated Langendorff-perfused rat heart) allowed us to distinguish which factor involved during ischemia, low coronary flow or low ...
B. Caro +3 more
openaire +3 more sources
[Other indications of thrombolysis: thrombolysis in the elderly, late thrombolysis].
Archives des maladies du coeur et des vaisseaux, 1992Thrombolytic therapy has been shown to preserve left ventricular function and reduce mortality in the acute phase of myocardial infarction. When the usual inclusion criteria are respected, only about 30% of patients can benefit from this form of treatment. The "excluded" cases are more numerous and have a worse prognosis.
A, Vahanian +3 more
openaire +1 more source
Australian and New Zealand Journal of Medicine, 1993
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources